3 Results for "

SCCHN

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "SCCHN" in MCE Product Catalog:

3
3 Cited Publications
Art. -Nr.: HY-P99208
CAS. Nr.: 1000676-41-4
Synonyms: IPH2102

Forschungsgebiete:  

Cancer

Lirilumab (IPH2102) is an anti-KIR monoclonal antibody, and shows antitumor activity. Lirilumab can be used in Leukemia, squamous cell carcinoma of the head and neck (SCCHN) research .
loading...
    loading...
Art. -Nr.: HY-P991244

Target:  

EGFR

Forschungsgebiete:  

Cancer

REGN-1400 is a humanized monoclonal antibody inhibitor targeting ErbB3. REGN-1400 reduces tumor cell proliferation by inhibiting ErbB3 and blocking related signaling pathways. REGN-1400 is promising for research of solid tumors such as non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and squamous cell carcinoma of the head and neck (SCCHN) .
loading...
    loading...
Art. -Nr.: HY-183402
CAS. Nr.: 917813-60-6
Synonyms: GO-Y026
Forschungsgebiete:  

Cancer

FLLL12 (GO-Y026) is a curcumin analog anticancer agent. FLLL12 inhibits the phosphorylation of AKT, Bcl-2, Bid, EGFR, mTOR, FOXO1a, FOXO3a, STAT3, HER2/neu, as well as pancreatic AKT/STAT3; upregulates the expression of Bim and DR5; and activates PTPs. FLLL12 regulates downstream pathways, induces mitochondria-mediated and DR5-dependent extrinsic apoptosis, inhibits cancer cell viability, proliferation, anchorage-independent growth and migration, and exerts a synergistic effect with Doxorubicin (HY-15142A). FLLL12 can be used in research related to head and neck squamous cell carcinoma, breast cancer, prostate cancer, pancreatic cancer, lung cancer, colon cancer and colorectal cancer .
loading...
    loading...